Eculizumab impairs killing of Neisseria meningitidis serogroup B in atypical hemolytic uremic syndrome patients vaccinated with MenB-4C

Bryan van den Broek, Michiel van der Flier, Nicole C.A.J. van de Kar, Jack F.M. Wetzels, Marien I. de Jonge, Ronald de Groot, Kioa L. Wijnsma, Jeroen D. Langereis*

*Corresponding author for this work

Research output: Contribution to journalLetterAcademicpeer-review

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)1293-1295
Number of pages3
JournalKidney International
Volume101
Issue number6
DOIs
Publication statusPublished - Jun 2022

Cite this